A Re-Appraisal of the Benefit-Risk Profile of Hydroxyurea in Polycythemia Vera: A Propensity-Matched Study

This analysis provides reliable and qualified estimates of the therapeutic profile of hydroxyurea and phlebotomy treatments for future experimental studies and for the management of polycythemia vera in clinical practice. 

 Am J Hematol

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.